Abstract
Full text available
CNS & Neurological Disorders - Drug Targets
Title:Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary)
Volume: 11 Issue: 1
Author(s): Russell J. Andrews
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
J. Andrews Russell, Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary), CNS & Neurological Disorders - Drug Targets 2012; 11 (1) . https://dx.doi.org/10.2174/187152712799960754
DOI https://dx.doi.org/10.2174/187152712799960754 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Oxide: Target for Therapeutic Strategies in Alzheimers Disease
Current Pharmaceutical Design Pathogens and Chronic or Long-Term Neurologic Disorders
Cardiovascular & Hematological Disorders-Drug Targets Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates
Current Topics in Medicinal Chemistry Hybrid SPECT/CT Imaging in Neurology
Current Radiopharmaceuticals Origin and Expansion of Trinucleotide Repeats and Neurological Disorders
Current Genomics Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Bone Marrow-Derived Mesenchymal Stem Cells Contribute to the Reduction of Amyloid-β Deposits and the Improvement of Synaptic Transmission in a Mouse Model of Pre-Dementia Alzheimer’s Disease
Current Alzheimer Research Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Medication-precipitated Seizure in Psychiatric Patients: Typical vs. Atypical Antipsychotics
Current Psychopharmacology Laterality of Brain Activation for Risk Factors of Addiction
Current Drug Abuse Reviews Analysis of Functional Brain Images Using Population-Based Probabilistic Atlas
Current Medical Imaging Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Current Medicinal Chemistry Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
Current Medicinal Chemistry Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications
Current Drug Metabolism Nutrition and Bone Health: Its Relationship to Osteoporosis
Current Nutrition & Food Science Overview of Pediatric Epilepsy
Current Pediatric Reviews Central Serotonin2C Receptor: From Physiology to Pathology
Current Topics in Medicinal Chemistry Role of Quercetin in the Mitigation of Lindane Induced Toxicity in Terms of Oxidative Responses and Metabolic Status in Mice Brain
Current Bioactive Compounds